Siemens Healthineers Forecast, price target & analysts
Siemens Healthineers Target price 2026 - Analyst rating & recommendation
Siemens Healthineers Classifications & Recommendation:
Siemens Healthineers Price Target
| Target Price | €56.61 |
| Price | €44.14 |
| Potential | 28.25% |
| Number of Estimates | 25 |
| 25 Analysts have issued a price target Siemens Healthineers 2027 . The average Siemens Healthineers target price is €56.61. This is 28.25% higher than the current stock price. The highest price target is €68.25 54.62% , the lowest is €45.45 2.97% . | |
| A rating was issued by 27 analysts: 20 Analysts recommend Siemens Healthineers to buy, 6 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Siemens Healthineers stock has an average upside potential 2027 of 28.25% . Most analysts recommend the Siemens Healthineers stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2030
25 Analysts have issued a sales forecast Siemens Healthineers 2026 . The average Siemens Healthineers sales estimate is €24.4b . This is 4.53% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €25.9b 10.61% , the lowest is €23.3b 0.22% .
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | €23.4b | 4.53% |
|---|---|---|
| 2026 | €24.4b | 4.53% |
| 2027 | €26.0b | 6.25% |
| 2028 | €27.6b | 6.34% |
| 2029 | €29.8b | 8.03% |
| 2030 | €31.6b | 5.85% |
23 Analysts have issued an Siemens Healthineers EBITDA forecast 2026. The average Siemens Healthineers EBITDA estimate is €5.0b . This is 11.73% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €5.6b 25.07% , the lowest is €4.6b 2.60% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | €4.5b | 10.62% |
|---|---|---|
| 2026 | €5.0b | 11.70% |
| 2027 | €5.5b | 11.26% |
| 2028 | €6.0b | 8.95% |
| 2029 | €6.7b | 10.27% |
| 2030 | €7.2b | 8.14% |
EBITDA Margin
| 2025 | 19.08% | 5.83% |
|---|---|---|
| 2026 | 20.39% | 6.86% |
| 2027 | 21.35% | 4.71% |
| 2028 | 21.87% | 2.44% |
| 2029 | 22.33% | 2.10% |
| 2030 | 22.81% | 2.15% |
25 Siemens Healthineers Analysts have issued a net profit forecast 2026. The average Siemens Healthineers net profit estimate is €2.7b . This is 24.09% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.9b 36.41% , the lowest is €2.5b 15.37% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | €2.1b | 10.40% |
|---|---|---|
| 2026 | €2.7b | 24.09% |
| 2027 | €3.0b | 13.77% |
| 2028 | €3.4b | 13.47% |
| 2029 | €3.9b | 14.54% |
| 2030 | €4.1b | 3.38% |
Net Margin
| 2025 | 9.17% | 5.62% |
|---|---|---|
| 2026 | 10.89% | 18.73% |
| 2027 | 11.66% | 7.07% |
| 2028 | 12.44% | 6.69% |
| 2029 | 13.19% | 6.03% |
| 2030 | 12.88% | 2.35% |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
25 Analysts have issued a Siemens Healthineers forecast for earnings per share. The average Siemens Healthineers EPS is €2.38 . This is 25.26% higher than earnings per share in the financial year 2025. The highest EPS forecast is €2.62 37.89% , the lowest is €2.21 16.32% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | €1.91 | 10.40% |
|---|---|---|
| 2026 | €2.38 | 24.61% |
| 2027 | €2.71 | 13.87% |
| 2028 | €3.08 | 13.65% |
| 2029 | €3.52 | 14.29% |
| 2030 | €3.64 | 3.41% |
P/E ratio
| Current | 23.23 | 22.86% |
|---|---|---|
| 2026 | 18.53 | 20.24% |
| 2027 | 16.29 | 12.09% |
| 2028 | 14.35 | 11.91% |
| 2029 | 12.53 | 12.68% |
| 2030 | 12.12 | 3.27% |
Based on analysts' sales estimates for 2026, the Siemens Healthineers stock is valued at an EV/Sales of 2.55 and an P/S ratio of 2.05 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 2.67 | 17.08% |
|---|---|---|
| 2026 | 2.55 | 4.34% |
| 2027 | 2.40 | 5.88% |
| 2028 | 2.26 | 5.97% |
| 2029 | 2.09 | 7.44% |
| 2030 | 1.98 | 5.52% |
P/S ratio
| Current | 2.14 | 18.37% |
|---|---|---|
| 2026 | 2.05 | 4.33% |
| 2027 | 1.93 | 5.88% |
| 2028 | 1.82 | 5.96% |
| 2029 | 1.68 | 7.44% |
| 2030 | 1.59 | 5.52% |
Siemens Healthineers...
Current Siemens Healthineers Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DAY BY DAY |
Sell
➜
Sell
|
Unchanged | Dec 09 2025 |
| JEFFERIES |
Buy
➜
Buy
|
Unchanged | Dec 03 2025 |
| METZLER EQUITIES |
Buy
➜
Hold
|
Downgrade | Nov 28 2025 |
| ODDO BHF |
Buy
➜
Buy
|
Unchanged | Nov 27 2025 |
| HSBC GLOBAL INVESTMENT RESEARCH |
Buy
➜
Buy
|
Unchanged | Nov 25 2025 |
| BERENBERG |
Buy
➜
Buy
|
Unchanged | Nov 24 2025 |
| DZ BANK |
Buy
➜
Buy
|
Unchanged | Nov 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
DAY BY DAY:
Sell
➜
Sell
|
Dec 09 2025 |
|
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Dec 03 2025 |
|
Downgrade
METZLER EQUITIES:
Buy
➜
Hold
|
Nov 28 2025 |
|
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Nov 27 2025 |
|
Unchanged
HSBC GLOBAL INVESTMENT RESEARCH:
Buy
➜
Buy
|
Nov 25 2025 |
|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Nov 24 2025 |
|
Unchanged
DZ BANK:
Buy
➜
Buy
|
Nov 10 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
